158 related articles for article (PubMed ID: 11005777)
1. Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica.
Ellingsen T; Elling P; Olson A; Elling H; Baandrup U; Matsushima K; Deleuran B; Stengaard-Pedersen K
Ann Rheum Dis; 2000 Oct; 59(10):775-80. PubMed ID: 11005777
[TBL] [Abstract][Full Text] [Related]
2. Expression of the class I interferon-related MxA protein in temporal arteries in polymyalgia rheumatica and temporal arteritis.
Nordborg C; Larsson K; Aman P; Nordborg E
Scand J Rheumatol; 2009; 38(2):144-8. PubMed ID: 19177264
[TBL] [Abstract][Full Text] [Related]
3. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
[TBL] [Abstract][Full Text] [Related]
4. Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity.
Grau RG; Kassan SS; Franks JJ; Kaplan H; Walker SH; Tan EM
Ann Rheum Dis; 1984 Oct; 43(5):721-4. PubMed ID: 6497463
[TBL] [Abstract][Full Text] [Related]
5. Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.
Braun N; Fritz P; Rieth A; Schroth W; Kimmel M; Biegger D; Zakim D; Alscher MD
J Rheumatol; 2009 Oct; 36(10):2269-76. PubMed ID: 19684157
[TBL] [Abstract][Full Text] [Related]
6. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
Front Immunol; 2019; 10():1981. PubMed ID: 31507597
[TBL] [Abstract][Full Text] [Related]
8. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
[TBL] [Abstract][Full Text] [Related]
9. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of calprotectin in patients with polymyalgia rheumatica or temporal arteritis: relation to disease activity.
Brun JG; Madland TM; Gran JT; Myklebust G
Scand J Rheumatol; 2005; 34(2):125-8. PubMed ID: 16095008
[TBL] [Abstract][Full Text] [Related]
11. [Rheumatic polymyalgia and temporal arteritis. Case contribution and bibliographic review].
Manganelli P; Mercadanti M; Nervetti A; Ambanelli U
Minerva Med; 1987 Mar; 78(5):287-96. PubMed ID: 3822219
[TBL] [Abstract][Full Text] [Related]
12. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Chalan P; Rutgers A; Horst G; Huitema MG; Roffel MP; Roozendaal C; Kluin PM; Bos NA; Boots AM; Brouwer E
Arthritis Rheumatol; 2014 Jul; 66(7):1927-38. PubMed ID: 24623536
[TBL] [Abstract][Full Text] [Related]
13. Serological and immunohistochemical determination of von Willebrand factor antigen in serum and biopsy specimens from patients with arteritis temporalis and polymyalgia rheumatica.
Olsson A; Elling P; Elling H
Clin Exp Rheumatol; 1990; 8(1):55-8. PubMed ID: 2189625
[TBL] [Abstract][Full Text] [Related]
14. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
[TBL] [Abstract][Full Text] [Related]
15. No permanent reduction in bone mineral density during treatment of polymyalgia rheumatica and temporal arteritis using low dose corticosteroids.
Haugeberg G; Myklebust G; Dovland H; Mikkelsen B; Gran JT
Scand J Rheumatol; 2000; 29(3):163-9. PubMed ID: 10898068
[TBL] [Abstract][Full Text] [Related]
16. Temporal arteritis and polymyalgia rheumatica in north-eastern Spain: clinical spectrum and relationship over a 15 year period.
Narváez J; Nolla-Solé JM; Clavaguera MT; Valverde-García J; Roig-Escofet D
Joint Bone Spine; 2003 Feb; 70(1):33-9. PubMed ID: 12639615
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study of von Willebrand factor in patients with temporal arteritis].
González-Gay MA; Alvarez MD; Machín AJ; Alonso MD; García González J; Cereijo MJ; Bal M
An Med Interna; 1992 Oct; 9(10):483-6. PubMed ID: 1420759
[TBL] [Abstract][Full Text] [Related]
18. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection.
Elling P; Olsson AT; Elling H
J Rheumatol; 1996 Jan; 23(1):112-9. PubMed ID: 8838518
[TBL] [Abstract][Full Text] [Related]
19. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
[TBL] [Abstract][Full Text] [Related]
20. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
